Serum markers of ovarian reserve and ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age

Laura Detti, Rebecca A. Uhlmann, Meifen Lu, Michael P. Diamond, Ghassan M. Saed, Nicole M. Fletcher, Jie Zhang, Lucy J. Williams

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: AMH is used to quantify the extent of follicular pool in postpubertal women, but its value after chemotherapy is unclear. We tested AMH as a marker of follicular reserve in adult mice treated with cyclophosphamide (CTX) in prepubertal age. Methods: Mice received placebo or CTX at age 18 days. AMH and FSH were assessed on day 43, 56, and 95 of life. Ovaries were fixed in formalin, embedded in paraffin, and stained with H&E and TUNEL. Follicular apoptosis was graded. Results: All mice exposed to CTX had a decreased number of follicles/mm2 and significantly decreased AMH, but only 48 % of pubertal and 81 % of adult mice had increased FSH. Over time, there was an increase in FSH (p < 0.05), but not a concurrent decrease in AMH, while in controls, FSH remained stable and AMH decreased. There was no correlation between histological and serological markers. Conclusions: CTX administration to pre-pubertal mice caused various degrees of residual function, which were reflected by FSH, but not by AMH or by the number of ovarian follicles. AMH served as a marker of quantitative, and FSH of qualitative, residual ovarian function.

Original languageEnglish (US)
Pages (from-to)1421-1429
Number of pages9
JournalJournal of Assisted Reproduction and Genetics
Volume30
Issue number11
DOIs
StatePublished - Nov 1 2013

Fingerprint

Cyclophosphamide
Histology
Biomarkers
Ovarian Follicle
In Situ Nick-End Labeling
Paraffin
Formaldehyde
Ovary
Placebos
Ovarian Reserve
Apoptosis
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Genetics
  • Obstetrics and Gynecology
  • Developmental Biology
  • Genetics(clinical)

Cite this

Serum markers of ovarian reserve and ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age. / Detti, Laura; Uhlmann, Rebecca A.; Lu, Meifen; Diamond, Michael P.; Saed, Ghassan M.; Fletcher, Nicole M.; Zhang, Jie; Williams, Lucy J.

In: Journal of Assisted Reproduction and Genetics, Vol. 30, No. 11, 01.11.2013, p. 1421-1429.

Research output: Contribution to journalArticle

Detti, Laura ; Uhlmann, Rebecca A. ; Lu, Meifen ; Diamond, Michael P. ; Saed, Ghassan M. ; Fletcher, Nicole M. ; Zhang, Jie ; Williams, Lucy J. / Serum markers of ovarian reserve and ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age. In: Journal of Assisted Reproduction and Genetics. 2013 ; Vol. 30, No. 11. pp. 1421-1429.
@article{c6ce1de1a24c414ea9921a2b1c91d59a,
title = "Serum markers of ovarian reserve and ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age",
abstract = "Purpose: AMH is used to quantify the extent of follicular pool in postpubertal women, but its value after chemotherapy is unclear. We tested AMH as a marker of follicular reserve in adult mice treated with cyclophosphamide (CTX) in prepubertal age. Methods: Mice received placebo or CTX at age 18 days. AMH and FSH were assessed on day 43, 56, and 95 of life. Ovaries were fixed in formalin, embedded in paraffin, and stained with H&E and TUNEL. Follicular apoptosis was graded. Results: All mice exposed to CTX had a decreased number of follicles/mm2 and significantly decreased AMH, but only 48 {\%} of pubertal and 81 {\%} of adult mice had increased FSH. Over time, there was an increase in FSH (p < 0.05), but not a concurrent decrease in AMH, while in controls, FSH remained stable and AMH decreased. There was no correlation between histological and serological markers. Conclusions: CTX administration to pre-pubertal mice caused various degrees of residual function, which were reflected by FSH, but not by AMH or by the number of ovarian follicles. AMH served as a marker of quantitative, and FSH of qualitative, residual ovarian function.",
author = "Laura Detti and Uhlmann, {Rebecca A.} and Meifen Lu and Diamond, {Michael P.} and Saed, {Ghassan M.} and Fletcher, {Nicole M.} and Jie Zhang and Williams, {Lucy J.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1007/s10815-013-0087-x",
language = "English (US)",
volume = "30",
pages = "1421--1429",
journal = "Journal of Assisted Reproduction and Genetics",
issn = "1058-0468",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Serum markers of ovarian reserve and ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age

AU - Detti, Laura

AU - Uhlmann, Rebecca A.

AU - Lu, Meifen

AU - Diamond, Michael P.

AU - Saed, Ghassan M.

AU - Fletcher, Nicole M.

AU - Zhang, Jie

AU - Williams, Lucy J.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Purpose: AMH is used to quantify the extent of follicular pool in postpubertal women, but its value after chemotherapy is unclear. We tested AMH as a marker of follicular reserve in adult mice treated with cyclophosphamide (CTX) in prepubertal age. Methods: Mice received placebo or CTX at age 18 days. AMH and FSH were assessed on day 43, 56, and 95 of life. Ovaries were fixed in formalin, embedded in paraffin, and stained with H&E and TUNEL. Follicular apoptosis was graded. Results: All mice exposed to CTX had a decreased number of follicles/mm2 and significantly decreased AMH, but only 48 % of pubertal and 81 % of adult mice had increased FSH. Over time, there was an increase in FSH (p < 0.05), but not a concurrent decrease in AMH, while in controls, FSH remained stable and AMH decreased. There was no correlation between histological and serological markers. Conclusions: CTX administration to pre-pubertal mice caused various degrees of residual function, which were reflected by FSH, but not by AMH or by the number of ovarian follicles. AMH served as a marker of quantitative, and FSH of qualitative, residual ovarian function.

AB - Purpose: AMH is used to quantify the extent of follicular pool in postpubertal women, but its value after chemotherapy is unclear. We tested AMH as a marker of follicular reserve in adult mice treated with cyclophosphamide (CTX) in prepubertal age. Methods: Mice received placebo or CTX at age 18 days. AMH and FSH were assessed on day 43, 56, and 95 of life. Ovaries were fixed in formalin, embedded in paraffin, and stained with H&E and TUNEL. Follicular apoptosis was graded. Results: All mice exposed to CTX had a decreased number of follicles/mm2 and significantly decreased AMH, but only 48 % of pubertal and 81 % of adult mice had increased FSH. Over time, there was an increase in FSH (p < 0.05), but not a concurrent decrease in AMH, while in controls, FSH remained stable and AMH decreased. There was no correlation between histological and serological markers. Conclusions: CTX administration to pre-pubertal mice caused various degrees of residual function, which were reflected by FSH, but not by AMH or by the number of ovarian follicles. AMH served as a marker of quantitative, and FSH of qualitative, residual ovarian function.

UR - http://www.scopus.com/inward/record.url?scp=84890540457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890540457&partnerID=8YFLogxK

U2 - 10.1007/s10815-013-0087-x

DO - 10.1007/s10815-013-0087-x

M3 - Article

VL - 30

SP - 1421

EP - 1429

JO - Journal of Assisted Reproduction and Genetics

JF - Journal of Assisted Reproduction and Genetics

SN - 1058-0468

IS - 11

ER -